KR101627850B1 - Method of fermentation using complex strains and cosmetic composition comprising thereof - Google Patents

Method of fermentation using complex strains and cosmetic composition comprising thereof Download PDF

Info

Publication number
KR101627850B1
KR101627850B1 KR1020147009394A KR20147009394A KR101627850B1 KR 101627850 B1 KR101627850 B1 KR 101627850B1 KR 1020147009394 A KR1020147009394 A KR 1020147009394A KR 20147009394 A KR20147009394 A KR 20147009394A KR 101627850 B1 KR101627850 B1 KR 101627850B1
Authority
KR
South Korea
Prior art keywords
lactobacillus
paracasei
kccm11349p
kccm11254p
present
Prior art date
Application number
KR1020147009394A
Other languages
Korean (ko)
Other versions
KR20150020521A (en
Inventor
이현용
최우석
최운용
김남영
권희석
임혜원
Original Assignee
서원대학교산학협력단
주식회사 세바바이오텍
주식회사 한국코스모
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 서원대학교산학협력단, 주식회사 세바바이오텍, 주식회사 한국코스모 filed Critical 서원대학교산학협력단
Publication of KR20150020521A publication Critical patent/KR20150020521A/en
Application granted granted Critical
Publication of KR101627850B1 publication Critical patent/KR101627850B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/82Preparation or application process involves sonication or ultrasonication
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

본 발명은 인체 유래의 락토바실러스 람노서스(Lactobacillus rhamnosus) HK-9와 락토바실러스 파라카제이(Lactobacillus paracasei) HS-05 복합 유산균을 이용한 발효물의 제조방법 및 상기 발효물을 함유한 항산화 및 피부미백 효능을 갖는 기능성 화장료 조성물에 관한 것이다. 인체 유래의 락토바실러스 람노서스(Lactobacillus rhamnosus) HK-9와 락토바실러스 파라카제이(Lactobacillus paracasei) HS-05 유산균의 열수추출물 및 상기 균주를 이용한 황금 발효물질은 높은 항산화 및 피부 미백 활성을 보였으며, 더 많은 생리활성 물질 및 유효물질을 용출하여 적은 양으로도 최대의 효과를 가져다 줄 수 있어 경제적으로도 유리한 효과가 있다.The present invention relates to a human-derived Lactobacillus lambosus rhamnosus ) HK-9 and Lactobacillus paracasei paracasei HS-05 complex lactic acid bacteria and a functional cosmetic composition having antioxidative and skin whitening effect containing the fermented product. Human-derived Lactobacillus Lactobacillus rhamnosus HK-9 and Lactobacillus paracasei The hot-water extract of Lactobacillus paracasei HS-05 lactic acid bacteria and the fermented fermenting material using the strain showed high antioxidative and whitening activity, and more physiologically active substances and effective substances It is possible to obtain the maximum effect even with a small amount of elution, which is economically advantageous.

Description

인체 유래 복합 균주를 이용한 발효물의 제조방법 및 상기 발효물을 함유한 기능성 화장료 조성물{Method of fermentation using complex strains and cosmetic composition comprising thereof}[0001] The present invention relates to a method for producing a fermented product using a human strain derived complex strain, and a functional cosmetic composition containing the fermented product,

본 발명은 인체 유래의 락토바실러스 람노서스(Lactobacillus rhamnosus) HK-9과 락토바실러스 파라카제이(Lactobacillus paracasei) HS-05 복합 유산균을 이용한 발효물의 제조방법 및 상기 발효물을 함유한 항산화 및 피부미백 효능을 갖는 기능성 화장료 조성물에 관한 것이다.The present invention relates to a human-derived Lactobacillus lambosus rhamnosus ) HK-9 and Lactobacillus paracase paracasei HS-05 complex lactic acid bacteria and a functional cosmetic composition having antioxidative and skin whitening effect containing the fermented product.

멜라닌은 태양광선 중 유해한 자외선으로부터 생체를 보호하는 중요한 수단으로 동물, 식물 및 미생물에 널리 존재하는 페놀류의 고분자 물질로 자외선, 건조, 극한온도 등에 대한 생존 능력을 높여주지만, 과도한 멜라닌 생성은 인체에 기미, 주근깨, 검버섯을 형성하고 피부노화를 촉진시키며, 악성 흑색종의 피부암 유발에 관여하는 것으로 알려져 있다. 더욱이 멜라닌은 화학적 물리적으로 매우 안정한 물질이어서, 일단 생성된 색소는 피부에 커다란 손상 없이 단기간에 분해하여 제거하기가 거의 불가능하기 때문에 이를 방지 및 치료하기 위한 방법으로 피부미백제로서 멜라닌의 합성을 저해하는 물질을 사용하고 있다. 또한, 식품에서는 채소, 과일, 생선 등의 갈변화 현상을 일으켜 품질을 저하시키는 문제점이 있다(Bell and Weeler, 1986; Chen et al., 1991; Lerner and Fitzpatrick, 1950). 멜라닌은 표피 기저층에 존재하는 멜라노사이트의 세포 내 멜라노솜(melanosome)에서 티로시나아제 효소의 연속적 산화반응으로 생합성된다.Melanin is an important means of protecting harmful ultraviolet rays from harmful ultraviolet rays of sunlight. It is a high molecular substance of phenols widely present in animals, plants and microorganisms, and enhances survival ability against ultraviolet ray, drying, extreme temperature, etc. However, excessive melanin production , Freckles, black blotch, accelerate skin aging, and is known to be involved in skin cancer induction of malignant melanoma. Furthermore, since melanin is chemically and physically very stable, it is almost impossible to decompose the melanin in a short period of time without significant damage to the skin. Therefore, a method for preventing and treating melanin is a substance that inhibits the synthesis of melanin . In addition, there is a problem in foods that causes a change in the quality of vegetables, fruits, fish, etc. (Bell and Weeler, 1986; Chen et al., 1991; Lerner and Fitzpatrick, 1950). Melanin is biosynthesized by the continuous oxidation of tyrosinase enzymes in the intracellular melanosomes of melanocytes in the epidermal basal layer.

티로시나아제는 멜라닌 생합성과정의 주요 엔자임으로 페놀화합물을 기질로 이용하는 구리 함유 효소이다. 티로신(Tyrosine)은 티로시나아제에 의하여 L-3,4-dihydroxyl-L-phenylalanine(LDOPA)로, L-DOPA를 도파퀴논(dopaquinone)으로 산화가 되고 이것이 다시 5,6-dihydroxy indole, indole 5,6-quinone으로 산화되어 최종적으로 중합에 의해 멜라닌이 생합성 된다(Lopez et al., 1992).Tyrosinase is a major enzyme of the melanin biosynthetic process and is a copper-containing enzyme that uses a phenolic compound as a substrate. Tyrosine is oxidized by tyrosinase to L-3,4-dihydroxyl-L-phenylalanine (LDOPA) and L-DOPA to dopaquinone, which is then converted to 5,6-dihydroxy indole, , 6-quinone, and melanin is biosynthesized by polymerization (Lopez et al., 1992).

티로시나아제 저해물질로 알려진 것에는 아스코르브산(ascorbic acid), 누룩산(kojic acid, Lee et al., 2006), 하이드로퀴논(hydroquinone, Fitton and Goa, 1991;Parvez et al., 2006), 벤조산(benzoic acid), 레티노이드(retinoid), 알부틴(arbutin, Maeda and Fukuda, 1996) 등이 있는데, 특히 코지산(kojic acid)과 알부틴(arbutin)은 강한 미백효과를 가지고 있으나 제품 안정성 및 경제성 등의 문제로 사용에 어려움이 있다(Ando et al., 1993; Masuda et al., 1996).Known as tyrosinase inhibitors are ascorbic acid, kojic acid (Lee et al., 2006), hydroquinone (Fitton and Goa, 1991; Parvez et al., 2006), benzoic acid benzoic acid, retinoid, and arbutin (Maeda and Fukuda, 1996). Especially, kojic acid and arbutin have strong whitening effect, but problems such as product stability and economical efficiency (Ando et al., 1993; Masuda et al., 1996).

따라서 부작용이 없고 비용이 저렴하여 안정성이 우수한 항산화 및 피부 미백용 화장료 개발이 필요한 실정이다.Therefore, it is necessary to develop cosmetics for antioxidation and skin whitening which are free from side effects and have low cost and excellent stability.

이에 본 발명자들은 인체에서 유래한 유산균인 락토바실러스 람노서스(Lactobacillus rhamnosus) HK-9 KCCM11349P 및 락토바실러스 파라카제이(Lactobacillus paracasei) HS-05 KCCM11254P를 복합적으로 발효하였을 때 이들 균주를 각각 발효하였을 때 보다 더 많은 생리활성 물질 및 유효물질을 용출하여 더 적은 양으로도 더 많은 효과를 가져다 줄 수 있음을 확인함으로써 본 발명을 완성하였다.Therefore, the present inventors have found that lactic acid bacteria derived from human body, such as Lactobacillus rhamnosus ) HK-9 KCCM11349P and Lactobacillus < RTI ID = 0.0 > paracasei ) HS-05 KCCM11254P was eluted with more physiologically active substance and effective substance than when each of these strains were fermented, and thus it was possible to obtain more effect in a smaller amount, thereby completing the present invention .

따라서 본 발명의 목적은 락토바실러스 람노서스(Lactobacillus rhamnosus) HK-9 KCCM11349P 및/또는 락토바실러스 파라카제이(Lactobacillus paracasei) HS-05 KCCM11254P 균주를 유효성분으로 함유하는 항산화 또는 피부 미백용 화장료 조성물을 제공하는 것이다.It is therefore an object of the present invention to provide a process for preparing Lactobacillus rhamnosus ) HK-9 KCCM11349P and / or Lactobacillus < RTI ID = 0.0 > paracasei ) HS-05 KCCM11254P strain as an active ingredient, and to provide a cosmetic composition for antioxidant or skin whitening.

본 발명의 다른 목적은 락토바실러스 람노서스(Lactobacillus rhamnosus) HK-9 KCCM11349P 및/또는 락토바실러스 파라카제이(Lactobacillus paracasei) HS-05 KCCM11254P 균주의 열수추출물을 유효성분으로 함유하는 항산화 또는 피부 미백용 화장료 조성물을 제공하는 것이다.Another object of the present invention is to provide a method for producing Lactobacillus < RTI ID = 0.0 > rhamnosus ) HK-9 KCCM11349P and / or Lactobacillus < RTI ID = 0.0 > paracasei ) HS-05 KCCM11254P strain as an active ingredient, and to provide a cosmetic composition for skin whitening.

본 발명의 다른 목적은 락토바실러스 람노서스(Lactobacillus rhamnosus) HK-9 KCCM11349P 및/또는 락토바실러스 파라카제이(Lactobacillus paracasei) HS-05 KCCM11254P 균주를 유효성분으로 함유하는 건강기능성식품을 제공하는 것이다.Another object of the present invention is to provide a method for producing Lactobacillus < RTI ID = 0.0 > rhamnosus ) HK-9 KCCM11349P and / or Lactobacillus < RTI ID = 0.0 > paracasei ) HS-05 strain KCCM11254P as an active ingredient.

나아가 본 발명의 목적은 항산화 또는 피부 미백용 화장료 조성물을 제조하는 방법을 제공하는 것이다.Further, it is an object of the present invention to provide a method for producing a cosmetic composition for antioxidant or skin whitening.

상기 목적을 달성하기 위하여, 본 발명은 락토바실러스 람노서스(Lactobacillus rhamnosus) HK-9 KCCM11349P 및/또는 락토바실러스 파라카제이(Lactobacillus paracasei) HS-05 KCCM11254P 균주를 유효성분으로 함유하는 항산화 또는 피부 미백용 화장료 조성물을 제공한다.In order to accomplish the above object, the present invention provides a pharmaceutical composition comprising Lactobacillus rhamnosus ) HK-9 KCCM11349P and / or Lactobacillus < RTI ID = 0.0 > paracasei ) HS-05 KCCM11254P strain as an active ingredient to provide an antioxidant or skin whitening cosmetic composition.

본 발명의 일실시예에 있어서, 상기 화장료 조성물은 황금 가루(Scutellaria baicalensis GEORGE)에 락토바실러스 람노서스(Lactobacillus rhamnosus) HK-9 KCCM11349P 및/또는 락토바실러스 파라카제이(Lactobacillus paracasei) HS-05 KCCM11254P 균주를 접종한 후 발효시켜 항산화 또는 피부 미백 효과를 발휘하는 것일 수 있다.In one embodiment of the present invention, the cosmetic composition is prepared by adding to a golden powder (Scutellaria baicalensis GEORGE) Lactobacillus rhamnosus ) HK-9 KCCM11349P and / or Lactobacillus < RTI ID = 0.0 > paracasei ) HS-05 KCCM11254P strain may be inoculated and then fermented to exhibit antioxidant or skin whitening effect.

본 발명은 락토바실러스 람노서스(Lactobacillus rhamnosus) HK-9 KCCM11349P 및/또는 락토바실러스 파라카제이(Lactobacillus paracasei) HS-05 KCCM11254P 균주의 열수추출물을 유효성분으로 함유하는 항산화 또는 피부 미백용 화장료 조성물을 제공한다.The present invention relates to Lactobacillus < RTI ID = 0.0 > rhamnosus ) HK-9 KCCM11349P and / or Lactobacillus < RTI ID = 0.0 > paracasei ) HS-05 A cosmetic composition for antioxidant or skin whitening comprising a hot-water extract of KCCM11254P strain as an active ingredient.

또한, 본 발명은 락토바실러스 람노서스(Lactobacillus rhamnosus) HK-9 KCCM11349P 및/또는 락토바실러스 파라카제이(Lactobacillus paracasei) HS-05 KCCM11254P 균주를 유효성분으로 함유하는 건강기능성식품을 제공한다.The present invention also relates to the use of Lactobacillus < RTI ID = 0.0 > rhamnosus ) HK-9 KCCM11349P and / or Lactobacillus < RTI ID = 0.0 > paracasei ) HS-05 KCCM11254P strain as an active ingredient.

나아가 본 발명은 (a) 락토바실러스 람노서스(Lactobacillus rhamnosus) HK-9 KCCM11349P 및/또는 락토바실러스 파라카제이(Lactobacillus paracasei) HS-05 KCCM11254P 균주 100ml을 20 ~ 50분 동안 50 ~ 60kHz의 초음파 처리하여 균주를 파쇄하는 단계; 및 (b) 상기 (a)단계에서 파쇄된 균주와 그 파쇄액을 50 ~ 70℃의 물 500㎖ ~ 1L을 첨가하여 12 ~ 24 시간동안 열수추출하는 단계를 포함하는 항산화 또는 피부 미백용 화장료 조성물을 제조하는 방법을 제공한다.Further, the present invention relates to a pharmaceutical composition comprising (a) Lactobacillus rhamnosus ) HK-9 KCCM11349P and / or Lactobacillus paracase (La ctobacillus paracasei ) HS-05 100 ml of KCCM11254P strain is sonicated at 50 to 60 kHz for 20 to 50 minutes to disrupt the strain; And (b) adding 500 ml to 1 L of water at 50 to 70 캜 to the strain and the disrupted lysate obtained in step (a), followed by hot water extraction for 12 to 24 hours. And a method for producing the same.

본 발명의 일실시예에 있어서, 상기 (a)단계의 천연물질은 황금, 가시오가피, 녹차, 녹두, 해바라기씨, 자목련 꽃, 모란 뿌리, 삼나무, 초마황, 해송잎, 백리향, 더덕, 도라지, 황기, 당귀, 애엽, 모과, 인삼 또는 산삼일 수 있다.In one embodiment of the present invention, the natural substance of step (a) is selected from the group consisting of gold, garlic, green tea, mung bean, sunflower seed, lily flower, peony root, cedar, , Angelica gigas, Lentil, Quercus, Ginseng or Wild ginseng.

본 발명은 인체 피부 유래의 락토바실러스 람노서스(Lactobacillus rhamnosus) HK-9와 락토바실러스 파라카제이(Lactobacillus paracasei) HS-05 복합 유산균을 이용한 발효물의 제조방법 및 상기 발효물을 함유한 항산화 및 피부미백 효능을 갖는 기능성 화장료 조성물에 관한 것으로서, 상기 균주를 복합적으로 발효하였을 때 이들 균주를 각각 발효하였을 때 보다 더 높은 항산화 및 피부 미백 활성을 보였으며, 더 많은 생리활성 물질 및 유효물질을 용출하여 적은 양으로도 최대의 효과를 가져다 줄 수 있어 경제적으로도 유리한 효과가 있다.The present invention relates to a pharmaceutical composition comprising Lactobacillus rhamnosus HK-9 derived from human skin and Lactobacillus parasite The present invention relates to a method for preparing a fermented product using the HS-05 complex lactic acid bacterium and to a functional cosmetic composition having antioxidative and skin whitening effect containing the fermented product. When the strain is fermented in a complex manner, It has a higher antioxidative and whitening activity. Further, it can exert the physiologically active substance and the active substance in a larger amount in a small amount, and thus has an economical advantage.

도 1은 Lactobacillus rhamnosus HK-9 KCCM11349P의 시간에 따른 균주 배양 정도를 측정한 그래프이다.
도 2는 Lactobacillus paracasei HS-05 KCCM11254P의 시간에 따른 균주 배양 정도를 측정한 그래프이다.
도 3은 Lactobacillus rhamnosus HK-9 KCCM11349P와 Lactobacillus paracasei HS-05 KCCM11254P 유산균을 복합 배양하였을 때의 시간에 따른 균주 배양 정도를 측정한 그래프이다.
도 4는 Lactobacillus rhamnosus HK-9 KCCM11349P군, Lactobacillus paracasei HS-05 KCCM11254P군, 본 발명의 상기 2가지 유산균을 복합 배양 발효한 군 및 대조군으로 일반 유산균인 Lactobacillus casei 발효 군을 대상으로 라디칼 소거능을 측정한 결과를 나타낸 그래프이다.
도 5는 Lactobacillus rhamnosus HK-9 KCCM11349P군, Lactobacillus paracasei HS-05 KCCM11254P군, 본 발명의 상기 2가지 유산균을 복합 배양 발효한 군 및 대조군으로 일반 유산균인 Lactobacillus casei 발효 군을 대상으로 환원력을 측정한 결과를 나타낸 그래프이다.
도 6은 Lactobacillus rhamnosus HK-9 KCCM11349P군, Lactobacillus paracasei HS-05 KCCM11254P군, 본 발명의 상기 2가지 유산균을 복합 배양 발효한 군 및 대조군으로 일반 유산균인 Lactobacillus casei 발효 군을 대상으로 멜라닌 합성 저해율을 측정한 결과를 나타낸 그래프이다.
도 7은 Lactobacillus rhamnosus HK-9 KCCM11349P군, Lactobacillus paracasei HS-05 KCCM11254P군, 본 발명의 상기 2가지 유산균을 복합 배양 발효한 군 및 대조군으로 일반 유산균인 Lactobacillus casei 발효 군을 대상으로 티로시네이즈 저해율을 측정한 결과를 나타낸 그래프이다.
Figure 1 is a graphical representation of Lactobacillus rhamnosus HK-9 < / RTI > KCCM11349P.
Figure 2 is a graph paracasei HS-05 < / RTI > KCCM11254P.
FIG. 3 is a graph showing the activity of Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei HS-05 KCCM11254P lactic acid bacteria.
Figure 4 is a graph rhamnosus HK-9 KCCM11349P group, Lactobacillus paracasei HS-05 KCCM11254P group, the two fermented lactic acid bacteria of the present invention and the control group, Lactobacillus casei FIG. 5 is a graph showing the results of measuring the radical scavenging ability of the fermentation group. FIG.
Figure 5 is a graph rhamnosus HK-9 KCCM11349P group, Lactobacillus paracasei HS-05 KCCM11254P group, the two fermented lactic acid bacteria of the present invention and the control group, Lactobacillus casei FIG. 5 is a graph showing the results of measuring the reducing power of the fermentation group. FIG.
Figure 6 is a graph rhamnosus HK-9 KCCM11349P group, Lactobacillus paracasei HS-05 KCCM11254P group, the two fermented lactic acid bacteria of the present invention and the control group, Lactobacillus casei FIG. 5 is a graph showing the results of measuring the inhibition rate of melanin synthesis in the fermentation group. FIG.
Figure 7 is a graphical representation of Lactobacillus rhamnosus HK-9 KCCM11349P group, Lactobacillus paracasei HS-05 KCCM11254P group, the two fermented lactic acid bacteria of the present invention and the control group, Lactobacillus casei FIG. 5 is a graph showing the result of measuring the inhibition rate of tyrosinase in a fermentation group. FIG.

발명의 실시를 위한 최선의 형태Best Mode for Carrying Out the Invention

본 발명은 인체 피부 유래의 락토바실러스 람노서스(Lactobacillus rhamnosus) HK-9와 락토바실러스 파라카제이(Lactobacillus paracasei) HS-05 복합 유산균을 이용한 발효물의 제조방법 및 상기 발효물을 함유한 항산화 및 피부미백 효능을 갖는 기능성 화장료 조성물을 제공함에 그 특징이 있다.The present invention relates to a pharmaceutical composition comprising Lactobacillus rhamnosus HK-9 derived from human skin and Lactobacillus parasite paracasei HS-05 complex lactic acid bacterium, and a functional cosmetic composition having antioxidative and skin whitening effect containing the fermented product.

최근 많은 여성들뿐만 아니라 남성의 경우에도 미용에 대한 관심이 급증하면서 피부미백, 여드름, 아토피 피부염 및 주름 개선을 위한 다양한 기능성 화장품들이 출시되고 있다. 그러나 시중에 판매되고 있는 대부분의 기능성 화장품의 경우, 합성 화합물을 사용한 제품들이 대부분인데 합성화합물이 첨가된 화장품은 피부에 따라 민감한 피부반응을 유발시킬 수 있어, 다양한 피부 부작용을 초래하는 문제점이 있다.In recent years, not only many women but also men have become increasingly interested in cosmetics, and various functional cosmetics for skin whitening, acne, atopic dermatitis and wrinkle are being released. However, most functional cosmetics sold on the market are products using synthetic compounds, and cosmetic products containing synthetic compounds can cause sensitive skin reactions depending on the skin, which causes various skin side effects.

이에 본 발명자들은 부작용이 없고 비용이 저렴하여 안정성이 우수한 피부 미백용 화장료 제조를 위하여 연구하고 있던 중 유산균에 주목하였다.Accordingly, the present inventors have focused on lactic acid bacteria, which have been studied for the production of a skin whitening cosmetic product having no side effects, low cost, and excellent stability.

유산균은 전 세계적으로 광범위하게 이용 및 응용되는 중요한 미생물이며 치즈, 발효유 및 유산균 음료 등의 발효 유제품과 김치, 청국장과 같은 식품산업에 오랫동안 사용되어 왔다. 유산균은 예로부터 장 질환에 대한 치료 및 예방의 정장효과를 가지고 있어 장내 유해균의 증식을 막고, 유익한 균의 생장에 좋은 조건을 만들어 주어 식중독 방지, 장내 부패방지, 변비예방, 발암 억제, 면역력의 증가 등의 여러 가지 생리활성을 가진다고 알려져 있어 다양한 유제품, 식품 및 화장품산업에 사용되고 있다.Lactic acid bacteria are important microorganisms widely used and applied worldwide, and they have been used for a long time in fermented dairy products such as cheese, fermented milk and lactic acid bacteria drink, and food industry such as kimchi and chungkukjang. Lactobacillus has a long-lasting effect on the treatment and prevention of intestinal diseases, thus preventing the growth of harmful bacteria in the intestines and making good conditions for the growth of beneficial bacteria, thereby preventing food poisoning, preventing intestinal decline, preventing constipation, And is used in various dairy products, foods, and cosmetics industries.

본 발명자들은 여자의 손이 남자의 손보다 부드럽고 유산균이 많이 존재한다는 점에 착안하여(The influence of sex handedness and washing on the diversity of hand surface bacteria, PNAS 105(46) 17994-17999) 여자 손에 많이 존재하는 유산균들을 동정 및 생리 활성 실험을 진행하여 그 중 2가지 종류의 Lactobacillus 속의 균을 선별하였고, 상기의 방법으로 얻어진 미생물을 국제 특허 기관에 기탁하여 기탁번호를 각각 KCCM11349P 및 KCCM11254P으로 부여받아 이를 “Lactobacillus rhamnosus HK-9 KCCM11349P”및 “Lactobacillus paracasei HS-05 KCCM11254P”로 명명하였다.The inventors of the present invention focused on the fact that the hand of a woman is softer than that of a man's hand and that lactic acid bacterium is abundantly present (PNAS 105 (46) 17994-17999) Two kinds of Lactobacillus spp. Were selected, and the microorganisms obtained by the above method were deposited in the international patent institution and assigned the deposit numbers as KCCM11349P and KCCM11254P respectively, Lactobacillus rhamnosus HK-9 KCCM11349P " and " Lactobacillus paracasei HS-05 KCCM11254P ".

본 발명의 일실시예에 따르면, 본 발명의 바실러스 람노서스(Lactobacillus rhamnosus) HK-9와 락토바실러스 파라카제이(Lactobacillus paracasei) HS-05 균주에 항산화 및 피부 미백 효과가 있는지를 알아보기 위하여 천연물인 황금에 Lactobacillus rhamnosus HK-9 KCCM11349P군, Lactobacillus paracasei HS-05 KCCM11254P군, 본 발명의 상기 2가지 유산균을 복합 배양 발효한 군 및 대조군으로 일반 유산균인 Lactobacillus casei 발효 군을 처리하여 DPPH 소거활성, 환원력 및 총 페놀 함량을 측정한 결과, Lactobacillus rhamnosus HK-9 KCCM11349P와 Lactobacillus paracasei HS-05 KCCM11254P를 복합 발효한 황금에서는 일반 유산균과 상기 균주를 각각 발효하였을 때보다 DPPH 소거활성, 환원력 및 총 페놀 함량이 높아, 높은 항산화 활성을 보임을 알 수 있었으며(표 1 참조), 이러한 효과는 상기 유산균을 파쇄하여 DPPH 소거활성 및 환원력을 측정하였을 때와 비슷한 결과를 보였다(도 4 내지 5).According to one embodiment of the present invention, Lactobacillus rhamnosus HK-9 of the present invention and Lactobacillus < RTI ID = 0.0 > paracasei ) HS-05 was tested for antioxidative and skin whitening effects. Lactobacillus rhamnosus HK-9 KCCM11349P group, Lactobacillus paracasei HS-05 KCCM11254P group, a group in which the two lactic acid bacteria of the present invention were combined and fermented and a control group, Lactobacillus casei The DPPH scavenging activity, reducing power and total phenol content of the fermented group were measured. As a result, Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei In the gold fermented with HS-05 KCCM11254P, the DPPH scavenging activity, the reducing power and the total phenol content were higher than that of the fermentation of the common lactic acid bacteria and the above strains, respectively, indicating high antioxidative activity (see Table 1) Showed results similar to those obtained when the lactic acid bacteria were disrupted to measure DPPH scavenging activity and reducing power (Figs. 4 to 5).

다른 일실시예 따르면 천연물인 황금에 Lactobacillus rhamnosus HK-9 KCCM11349P군, Lactobacillus paracasei HS-05 KCCM11254P군, 본 발명의 상기 2가지 유산균을 복합 배양 발효한 군 및 대조군으로 일반 유산균인 Lactobacillus casei 발효 군을 처리하여 멜라닌 합성 저해능과 티로시네이즈 저해능을 측정한 결과, Lactobacillus rhamnosus HK-9 KCCM11349P와 Lactobacillus paracasei HS-05 KCCM11254P를 복합 발효한 황금에서는 일반 유산균과 상기 균주를 각각 발효하였을 때보다 멜라닌 합성 저해능과 티로시네이즈 저해능이 월등히 높아 높은 미백 활성을 보임을 알 수 있었으며(표 2 참조), 이러한 효과는 상기 유산균을 파쇄하여 멜라닌 합성 저해능과 티로시네이즈 저해능을 측정하였을 때와 비슷한 결과를 보였다(도 6 내지 7).According to another embodiment, the natural gold, Lactobacillus rhamnosus HK-9 KCCM11349P group, Lactobacillus paracasei HS-05 KCCM11254P group, by treating the normal lactic acid fermentation of Lactobacillus casei group the above two lactic acid bacteria of the present invention in a group and the control group composite culture fermentation was measured melanin synthesis inhibition and tyrosinase inhibition tee, Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei In the gold fermented with HS-05 KCCM11254P, it was found that melanin synthesis inhibition and tyrosinase inhibition were significantly higher than those of fermentation of the common lactic acid bacteria and the strain, respectively (see Table 2) Similar results were obtained when the lactic acid bacteria were disrupted to measure melanin synthesis inhibition and tyrosinase inhibition (Figs. 6 to 7).

따라서 이러한 결과를 토대로 본 발명의 락토바실러스 람노서스(Lactobacillus rhamnosus) HK-9와 락토바실러스 파라카제이(Lactobacillus paracasei) HS-05 복합 유산균은 항산화 및 피부 미백 효과가 우수하므로 기능성 화장료 조성물을 제공할 수 있다.Therefore, based on these results, it was found that Lactobacillus rhamnosus HK-9 and Lactobacillus paracasei HS-05 complex lactic acid bacteria are excellent in antioxidative and skin whitening effects, and thus can provide a functional cosmetic composition.

본 발명에 따른 상기 균주는 화장료 조성물 총 중량에 대하여 0.001 ~ 20 중량%로 첨가할 수 있다.The strain according to the present invention may be added in an amount of 0.001 to 20% by weight based on the total weight of the cosmetic composition.

락토바실러스 람노서스(Lactobacillus rhamnosus) HK-9 KCCM11349P 및 락토바실러스 파라카제이(Lactobacillus paracasei) HS-05 KCCM11254P 복합 균주를 화장료 총 중량에 대해 0.001 중량% 미만으로 첨가하는 경우에는 본 발명의 화장료 조성물이 가지는 다양한 생리활성 효과를 나타내지 않으며, 반면 20 중량%를 초과하여 첨가될 경우에는 세포 등에 독성으로 작용하거나 또는 목적하는 효과를 첨가량에 비례하여 얻지 못하기 때문에 경제성을 고려하여 상기 기술된 범위 이내의 함량으로 첨가하는 것이 바람직하며, 또한 첨가량에 따른 화장료 조성물 가격이 상승되므로 경제적이지 못한 문제점이 있다.Lactobacillus Lactobacillus rhamnosus ) HK-9 KCCM11349P and Lactobacillus < RTI ID = 0.0 > paracasei ) When the HS-05 KCCM11254P complex is added in an amount of less than 0.001% by weight based on the total weight of the cosmetic composition, the cosmetic composition of the present invention does not exhibit various physiological activity effects. On the other hand, Or the desired effect can not be obtained in proportion to the added amount. Therefore, it is preferable to add the cosmetic composition in an amount within the range described above in consideration of economic efficiency, and the cost of the cosmetic composition according to the amount of the cosmetic composition increases, which is not economical .

본 발명의 조성물이 화장료 조성물로 제조되는 경우, 본 발명의 조성물은 상술한 복합 균주를 발효할 뿐만 아니라, 화장료 조성물에 통상적으로 이용되는 성분들을 포함할 수 있으며, 예컨대 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 그리고 담체를 포함할 수 있다.When the composition of the present invention is prepared with a cosmetic composition, the composition of the present invention not only ferments the above-mentioned complex strain, but may also contain components conventionally used in cosmetic compositions. Examples thereof include antioxidants, stabilizers, , Customary adjuvants such as vitamins, pigments and flavoring agents, and carriers.

본 발명의 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클린싱, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 유연 화장수, 영양 화장수, 영양 크림, 마사지 크림, 에센스, 아이 크림, 클렌징 크림, 클렌징 포옴, 클렌징 워터, 팩, 스프레이 또는 파우더의 제형으로 제조될 수 있다.The cosmetic composition of the present invention can be prepared into any of the formulations conventionally produced in the art and can be used as a solution, a suspension, an emulsion, a paste, a gel, a cream, a lotion, a powder, a soap, , Oil, powder foundation, emulsion foundation, wax foundation and spray, but is not limited thereto. More specifically, it can be manufactured in the form of a soft lotion, a nutritional lotion, a nutritional cream, a massage cream, an essence, an eye cream, a cleansing cream, a cleansing foam, a cleansing water, a pack, a spray or a powder.

본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, an animal oil, vegetable oil, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as the carrier component .

본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.In the case where the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. Especially, in the case of a spray, a mixture of chlorofluorohydrocarbons, propane / Propane or dimethyl ether.

본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the present invention is a solution or an emulsion, a solvent, a dissolving agent or an emulsifying agent is used as a carrier component, and examples thereof include water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, , 3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan fatty acid esters.

본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.In the case where the formulation of the present invention is a suspension, a carrier such as water, a liquid diluent such as ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Cellulose, aluminum metahydroxide, bentonite, agar or tracant, etc. may be used.

본 발명의 제형이 계면-활성제 함유 클린징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the present invention is an interfacial active agent-containing cleansing, the carrier component may include aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyltaurate, sarcosinate, fatty acid amide Ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, lanolin derivatives, or ethoxylated glycerol fatty acid esters.

또한, 본 발명은 본 발명의 화장료 조성물을 인간의 피부에 도포하는 것을 특징으로 하는 화장방법을 제공한다.The present invention also provides a cosmetic method characterized by applying the cosmetic composition of the present invention to human skin.

본 발명의 화장 방법은 본 발명의 화장료 조성물을 인간의 피부에 도포하는 모든 화장 방법을 일컫는다. 즉, 화장료 조성물을 피부에 도포하는 당업계에 공지된 모든 방법이 본 발명의 화장 방법에 속한다.The cosmetic process of the present invention refers to all the cosmetic processes for applying the cosmetic composition of the present invention to human skin. That is, all methods known in the art for applying the cosmetic composition to the skin belong to the cosmetic method of the present invention.

본 발명의 화장료 조성물은 단독 또는 중복 도포하여 사용하거나, 본 발명 이외의 다른 화장료 조성물과 중복 도포하여 사용할 수 있다. 또한 본 발명에 따른 피부 주름 개선 효과가 우수한 화장료 조성물은 통상적인 사용방법에 따라 사용될 수 있으며, 사용자의 피부 상태 또는 취향에 따라 그 사용횟수를 달리할 수 있다.The cosmetic composition of the present invention may be used alone or in combination, or may be used by overlapping with other cosmetic compositions other than the present invention. Further, the cosmetic composition having excellent skin wrinkle-improving effect according to the present invention can be used according to a conventional method of use, and the use frequency of the cosmetic composition can be changed according to a user's skin condition or taste.

본 발명의 화장료 조성물이 비누, 계면활성제 함유 클렌징 또는 계면활성제 비함유 클렌징 제형일 경우, 피부에 도포한 후 닦아내거나 떼거나 물로 씻어낼 수도 있다. 구체적인 예로서, 상기 비누는 액상비누, 가루비누, 고형비누 및 오일비누이며, 상기 계면활성제 함유 클린징 제형은 클렌징폼, 클렌징 워터, 클렌징 수건 및 클렌징 팩이며, 상기 계면활성제 비함유 클렌징 제형은 클렌징크림, 클렌징 로션, 클렌징 워터 및 클렌징 겔이며, 이에 한정되는 것은 아니다.When the cosmetic composition of the present invention is a soap, a surfactant-containing cleansing agent, or a surfactant-free cleansing agent, it may be applied to the skin and then wiped off or removed or washed with water. The surfactant-containing cleansing formulation is a cleansing foam, a cleansing water, a cleansing towel, and a cleansing pack. The surfactant-free cleansing formulation may be a cleansing cream, , Cleansing lotion, cleansing water and cleansing gel, but is not limited thereto.

이하 본 발명을 실시예에 의하여 더욱 상세하게 설명한다. 이들 실시예는 단지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 범위가 이들 실시예에 국한되지 않는다는 것은 당업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail with reference to Examples. It will be apparent to those skilled in the art that these embodiments are merely illustrative of the present invention and that the scope of the present invention is not limited to these embodiments.

발명의 실시를 위한 형태DETAILED DESCRIPTION OF THE INVENTION

<< 실시예Example 1> 1>

신균주인A new strain 락토바실러스Lactobacillus 람노서스Lambrosse KCCM11349PKCCM11349P  And 락토바실러스Lactobacillus 파라카제이Paracase KCCM11254P의 분리 Isolation of KCCM11254P

본 발명자들은 신규한 유산균 분리를 위해 20 ~ 40대 남녀 40명에게 실험실시 7일 전에 참여하도록 요청하였으며, 참가자들이 실험 전에 손 씻기 등의 위생 처리를 하지 않도록 미리 실험의 내용을 알리지 않고 불특정일에 실험을 진행하였다.In order to isolate the new lactic acid bacteria, the present inventors requested 40 male and female participants in the 20s and 40s to participate in the experiment 7 days before the experiment. In order to prevent the hygiene treatment such as hand washing before the experiment, The experiment was carried out.

미리 제작한 MRS agar 배지에 실험 참가자의 손바닥을 찍어, 손에 있는 초기 균을 접종하였으며, 30℃에서 24시간 혐기 배양 후 형성된 콜로니를 백금이로 새로운 MRS Agar 배지에 2차 접종하여 균주를 분리하였다. 2차 접종에서 분리한 균주를 콜로니별로 각각 새로운 10 ㎖ MRS broth에 옮겨 계대배양 하였으며, 콜로니별로 발효를 하여 가장 활성이 뛰어난 미생물 2개를 선택하였다.In the pre-prepared MRS agar medium, the palms of the participants were inoculated, and the initial bacteria in the hands were inoculated. After incubation at 30 ° C for 24 hours, the colonies were inoculated into the new MRS agar medium with platinum, . The strains isolated from the second inoculation were transferred to a new 10 ml MRS broth for each colony and subcultured. Two microorganisms with the highest activity were selected by fermentation for each colony.

상기의 방법으로 얻어진 미생물을 한국미생물보존센터에 의뢰하여, PCR을 이용한 유산균 식별을 하였으며, 상기 미생물을 국제 특허 기관에 기탁하였다.The microorganisms obtained by the above method were referred to the Korean Microorganism Conservation Center to identify lactic acid bacteria by PCR, and the microorganisms were deposited with the international patent institutions.

한국 미생물보존센터 결과, 본 발명에서 얻어진 신규한 2개의 균주는 락토바실러스(Lactobacillus) 속의 균주인 것을 확인 할 수 있었고, 본 발명자들은 상기 2가지 균주를 락토바실러스 람노서스(Lactobacillus rhamnosus) HK-9 및 락토바실러스 파라카제이(Lactobacillus paracasei) HS-05라고 명명하였으며, 각각의 균주를 한국미생물보존센터(Korean Culture Center of Microorganism)에 기탁하여 기탁번호 KCCM11349P 및 KCCM11254P를 부여받았다. 이하 본 발명에서는 상기 동정한 2가지의 신균주를 “Lactobacillus rhamnosus HK-9 KCCM11349P”및 “Lactobacillus paracasei HS-05 KCCM11254P”로 명명하였다.As a result of the Korean Microorganism Conservation Center, it was confirmed that the two novel strains obtained in the present invention are strains belonging to the genus Lactobacillus , and the present inventors have found that the two strains can be used as Lactobacillus rhamnosus HK-9 and Lactobacillus &lt; RTI ID = 0.0 &gt; paracasei HS-05, and each strain was deposited at the Korean Culture Center of Microorganism and assigned accession numbers KCCM11349P and KCCM11254P. In the present invention, the two new strains identified above are referred to as &quot; Lactobacillus rhamnosus HK-9 KCCM11349P &quot; and &quot; Lactobacillus paracasei HS-05 KCCM11254P &quot;.

<< 실시예Example 2> 2>

신균주인A new strain 락토바실러스Lactobacillus 람노서스Lambrosse KCCM11349PKCCM11349P  And 락토바실러스Lactobacillus 파라카제이Paracase KCCM11254P의 배양 방법 Culture method of KCCM11254P

본 발명자들은 상기 실시예1에서 분리한 2종의 인간 피부 유래 유산균인 Lactobacillus rhamnosus HK-9 KCCM11349P 및 Lactobacillus paracasei HS-05 KCCM11254P을 MRS agar 배지에 배양하여 균수가 최대가 되는 최적의 배양시간을 정한 후, 2ℓ 플라스크에 1ℓ의 증류수와 55%의 MRS broth 파우더와 0.5% L-cysteine hydrochloride를 첨가하여 배지를 제작하였다. 유산균의 배양온도는 36℃이며, 최소한의 교반속도 50 ~ 60rpm로 48시간동안 혐기 배양하여 실험을 진행하였다.The inventors of the present invention found that two kinds of human skin-derived lactic acid bacteria Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus After culturing the paracasei HS-05 KCCM11254P on MRS agar medium set by the optimal incubation time it is maximized the number of bacteria, was added to 1ℓ of distilled water and 55% of the MRS broth powder and 0.5% L-cysteine hydrochloride to 2ℓ flask, and the medium Respectively. The cultivation temperature of the lactic acid bacteria was 36 ° C, and the experiment was carried out by anaerobic culture for 48 hours at a minimum stirring speed of 50 to 60 rpm.

Lactobacillus rhamnosus HK-9 KCCM11349P의 시간에 따른 균주 배양 정도를 측정한 결과, Lactobacillus rhamnosus HK-9 KCCM11349P를 12시간 배양하였을 때 균수가 약 6.4 × 106 CFU/㎖로 존재하였고, 24시간 배양하였을 때 균수가 약 3.2 × 107 CFU/㎖로 개체 수로 증가되었으며, 48시간 배양하였을 때는 최대인 약 4.3 × 107 CFU/㎖까지 개체 수가 증가하였으나, 48시간 이상 배양하였을 때는 개체 수가 서서히 감소하는 것을 확인하였다. 따라서 본 발명의 Lactobacillus rhamnosus HK-9 KCCM11349P 균주의 최적 배양시간은 48시간임을 알 수 있었다(도 1 참조). Lactobacillus rhamnosus The culture of HK-9 strain KCCM11349P was measured at different time points. As a result, Lactobacillus rhamnosus When HK-9 KCCM11349P was cultured for 12 hours, the number of bacteria was 6.4 × 10 6 CFU / ㎖. When cultured for 24 hours, the number of bacteria was increased to 3.2 × 10 7 CFU / ㎖, The maximum number of individuals increased to about 4.3 × 10 7 CFU / ㎖, but the number of individuals gradually decreased when cultured for more than 48 hours. Therefore, the Lactobacillus rhamnosus The optimum incubation time of the strain HK-9 KCCM11349P was 48 hours (see FIG. 1).

Lactobacillus paracasei HS-05 KCCM11254P의 시간에 따른 균주 배양 정도를 측정한 결과, Lactobacillus paracasei HS-05 KCCM11254P를 12시간 경과하였을 때 균수가 약 6.1 × 106 CFU/㎖로 존재하였고, 24시간 배양하였을 때 균수가 약 3.0 × 107 CFU/㎖로 개체 수로 증가되었으며, 48시간 배양하였을 때는 최대인 약 4.1 × 107 CFU/㎖까지 개체 수가 증가하였으나, 48시간 이상 배양하였을 때는 개체 수가 서서히 감소하는 것을 확인할 수 있었다. 따라서 본 발명의 Lactobacillus paracasei HS-05 KCCM11254P 균주의 최적 배양시간도 48시간임을 알 수 있었다(도 2 참조). Lactobacillus paracasei HS-05 KCCM11254P was incubated with Lactobacillus paracasei When HS-05 KCCM11254P was cultured for 12 hours, the number of bacteria was 6.1 × 10 6 CFU / ㎖. When cultured for 24 hours, the number of bacteria was increased to 3.0 × 10 7 CFU / ㎖, and when cultured for 48 hours The maximum number of individuals was increased to 4.1 × 10 7 CFU / ㎖, but it was observed that the number of individuals gradually decreased when cultured for more than 48 hours. Therefore, it was found that the optimum incubation time of the Lactobacillus paracasei strain HS-05 KCCM11254P of the present invention was 48 hours (see FIG. 2).

또한, Lactobacillus rhamnosus HK-9 KCCM11349P와 Lactobacillus paracasei HS-05 KCCM11254P의 시간에 따른 복합 균주 배양 정도를 측정한 결과, Lactobacillus rhamnosus HK-9 KCCM11349P와 Lactobacillus paracasei HS-05 KCCM11254P의 2가지 균주를 12시간 복합 배양하였을 때 균수가 약 7.1 × 106 CFU/㎖로 나타났으며, 24시간 배양하였을 때는 균수가 약 4.2 × 107 CFU/㎖로 균수가 크게 증가되었고, 48시간 배양하였을 때는 최대인 약 4.7 × 107 CFU/㎖까지 개체 수가 증가하였으나, 48시간 이상 배양하였을 때는 개체 수가 서서히 감소하는 것을 확인할 수 있었다. 따라서, Lactobacillus rhamnosus HK-9 KCCM11349P와 Lactobacillus paracasei HS-05 KCCM11254P의 복합 배양의 최적 배양 시간은 48시간임을 알 수 있었으며, Lactobacillus rhamnosus HK-9 KCCM11349P와 Lactobacillus paracasei HS-05 KCCM11254P의 단독 배양 보다 상기 2균주의 복합 배양을 하였을 때 더욱 많은 세포 개체수가 배양되었음을 알 수 있었다(도 3 참조).In addition, Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei HS-05 KCCM11254P was incubated with Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei When the two strains of HS-05 KCCM11254P were cultured for 12 hours, the number of bacteria was about 7.1 × 10 6 CFU / ㎖. When cultured for 24 hours, the number of bacteria increased to about 4.2 × 10 7 CFU / ㎖, And the number of individuals was increased up to about 4.7 × 10 7 CFU / ㎖ when cultured for 48 hours. However, when cultured for more than 48 hours, the number of individuals gradually decreased. Thus, Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei The optimum incubation time for HS-05 KCCM11254P complex culture was 48 hours, and Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei It was found that more cell populations were cultured when the two cultures of the above two strains were cultured than the single culture of HS-05 KCCM11254P (see FIG. 3).

<< 실험예Experimental Example 1> 1>

천연물 발효를 통한 항산화 활성 증진 분석Analysis of Antioxidant Activity Enhancement through Natural Product Fermentation

본 발명의 Lactobacillus rhamnosus HK-9 KCCM11349P 및 Lactobacillus paracasei HS-05 KCCM11254P의 복합 발효에 항산화 활성 증진 효과가 있는지를 알아보기 위하여 하기와 같은 실험을 하였다.The Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei HS-05 KCCM11254P to enhance the antioxidant activity.

먼저, 2ℓ 플라스크에 100 g의 황금을 파우더 형태로 갈아서 첨가한 후, 1ℓ의 배양 배지를 만들었다. 상기 배지에 실시예 1의 Lactobacillus rhamnosus HK-9 KCCM11349P와 Lactobacillus paracasei HS-05 KCCM11254P 균주를 각각 5%(v/v)씩 첨가하여 복합 접종한 뒤 48시간 동안 발효하였으며, 발효액을 동결건조 시킨 후 파우더 형태로 만든 다음 DPPH 소거활성, 환원력 및 총 페놀 함량을 측정하였다.First, 100 g of gold was ground into a 2 L flask in powder form, and then 1 L of culture medium was prepared. The medium was supplemented with Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei HS-05 strain KCCM11254P was added at a concentration of 5% (v / v), and the mixture was inoculated and fermented for 48 hours. After the fermentation broth was lyophilized to powder form, DPPH scavenging activity, reducing power and total phenol content were measured .

Figure 112014033855249-pct00001
Figure 112014033855249-pct00001

그 결과, 피부유래 유산균인 Lactobacillus rhamnosus HK-9 KCCM11349P와 Lactobacillus paracasei HS-05 KCCM11254P를 발효하였을 때 일반 유산균 발효보다 DPPH 소거활성, 환원력 및 총 페놀 함량이 높아, 높은 항산화 활성을 보임을 알 수 있었으며, Lactobacillus rhamnosus HK-9 KCCM11349P와 Lactobacillus paracasei HS-05 KCCM11254P를 혼합하여 복합 발효한 황금에서는 최대 90%의 DPPH활성을 보여 Lactobacillus rhamnosus HK-9 KCCM11349P와 Lactobacillus paracasei HS-05 KCCM11254P 단독 발효에 비해 높은 항산화활성을 가지고 있음을 알 수 있었다.As a result, skin-derived lactic acid bacteria, Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei When HS-05 KCCM11254P was fermented, DPPH scavenging activity, reducing power and total phenol content were higher than that of general lactic acid fermentation, indicating that Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei HS-05 KCCM11254P were mixed to show the DPPH activity up to 90% in the combined fermented gold. Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei HS-05 KCCM11254P alone had higher antioxidant activity than the fermentation.

또한, 피부유래 유산균인 Lactobacillus rhamnosus HK-9 KCCM11349P와 Lactobacillus paracasei HS-05 KCCM11254P 발효균주 및 상기 두 균주의 복합물에서 총 페놀함량이 각각 6.49 ㎎/㎖, 5.69 ㎎/㎖, 7.08 ㎎/㎖으로 나타나 일반 유산균보다 2배 정도 높은 총 페놀 함량을 가지고 있어 본 발명의 피부 유래 유산균인 Lactobacillus rhamnosus HK-9 KCCM11349P 및 Lactobacillus paracasei HS-05 KCCM11254P는 일반 장내 유산균에 비해 항산화 활성이 월등히 높음을 알 수 있었다(표 1 참조).In addition, the skin-derived lactic acid bacteria, Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei The total phenol contents of the HS-05 KCCM11254P fermentation strain and the combination of the two strains were 6.49 mg / ml, 5.69 mg / ml and 7.08 mg / ml, respectively, Lactobacillus rhamnosus , a skin-derived lactic acid bacterium HK-9 KCCM11349P and Lactobacillus paracasei HS-05 KCCM11254P showed significantly higher antioxidant activity than the intestinal lactobacillus (see Table 1).

<< 실험예Experimental Example 2> 2>

천연물 발효를 통한 미백 활성 증진 분석Analysis of whitening activity enhancement through natural product fermentation

본 발명자들은 천연물 발효를 통한 미백 활성 증진을 알아보기 위하여 본 발명의 Lactobacillus rhamnosus HK-9 KCCM11349P, Lactobacillus paracasei HS-05 KCCM11254P 및 상기 두 균주의 복합 배양 발효물의 멜라닌 합성 저해능과 티로시네이즈 저해능을 측정하였다.To investigate the enhancement of whitening activity through natural product fermentation, the inventors of the present invention found that Lactobacillus rhamnosus HK-9 KCCM11349P, Lactobacillus paracasei HS-05 KCCM11254P and melanin synthesis inhibitory ability and tyrosinase inhibitory ability of the combined culture fermented product of the two strains were measured.

먼저, 2ℓ 플라스크에 100 g의 황금을 파우더 형태로 갈아서 첨가한 후, 1ℓ의 배양 배지를 만들었다. 상기 배지에 실시예 1의 Lactobacillus rhamnosus HK-9 KCCM11349P와 Lactobacillus paracasei HS-05 KCCM11254P 균주를 각각 5%(v/v)씩 첨가하여 복합 접종한 뒤 48시간 동안 발효하였으며, 발효액을 동결건조 시킨 후 파우더 형태로 만든 다음 멜라닌 합성 저해능과 티로시네이즈 저해능을 측정한 결과, 일반 유산균과 비교하였을 때 피부유래 유산균인 Lactobacillus rhamnosus HK-9 KCCM11349P와 Lactobacillus paracasei HS-05 KCCM11254P 발효균주 및 상기 두 균주의 복합물에서는 멜라닌 합성 저해능과 티로시네이즈 저해능이 높아 미백 활성이 있는 것을 알 수 있었으며, 특히 Lactobacillus rhamnosus HK-9 KCCM11349P와 Lactobacillus paracasei HS-05 KCCM11254P를 복합 발효하였을 때 멜라닌 합성 저해능은 42%, 티로시네이즈 저해능은 45%로 나타나 가장 높은 미백 활성을 보임을 알 수 있었다(표 2 참조).First, 100 g of gold was ground into a 2 L flask in powder form, and then 1 L of culture medium was prepared. The medium was supplemented with Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei HS-05 strain KCCM11254P was added at 5% (v / v), and the fermented broth was fermented for 48 hours. After the fermentation broth was lyophilized to powder form, melanin synthesis inhibition and tyrosinase inhibition were measured the skin-derived lactic acid bacteria when compared with normal lactic acid bacteria Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei HS-05 KCCM11254P the fermentation strain and the composite of the two strains was found that high melanin synthesis inhibition and tyrosinase inhibition tee with bleaching activity, in particular Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei When combined with HS-05 KCCM11254P, melanin synthesis inhibition was 42% and tyrosinase inhibition was 45%, indicating the highest whitening activity (see Table 2).

따라서 본 발명의 Lactobacillus rhamnosus HK-9 KCCM11349P와 Lactobacillus paracasei HS-05 KCCM11254P의 복합 발효는 일반 유산균 및 Lactobacillus rhamnosus HK-9 KCCM11349P와 Lactobacillus paracasei HS-05 KCCM11254P 각각의 단독 발효보다 유용생리활성 물질 및 유효성분들이 쉽게 용출되며 추출 효율도 좋음을 알 수 있었다.Therefore, the Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei The complex fermentation of HS-05 KCCM11254P was carried out using a conventional lactobacillus and Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei HS-05 KCCM11254P was found to be easier to elute the useful physiologically active substances and the active ingredients than the individual fermentation, and the extraction efficiency was also good.

Figure 112014033855249-pct00002
Figure 112014033855249-pct00002

<< 실험예Experimental Example 3> 3>

피부유래Derived from skin 유산균  Lactobacillus 파쇄물의Crushed 항산화 활성 검증 Antioxidant activity verification

본 발명자들은 본 발명의 Lactobacillus rhamnosus HK-9 KCCM11349P와 Lactobacillus paracasei HS-05 KCCM11254P를 복합 배양하여 균주 자체에서 나오는 항산화 활성 물질의 효능을 검증하기 위하여 라디칼 소거능 실험(Radical scavenging activity)과 환원력 측정 실험(Reducing power)을 진행하였다.The present inventors have found that the Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei Radical scavenging activity and Reducing power were tested in order to examine the efficacy of antioxidant activity of HS-05 KCCM11254P.

먼저, 각각 배양된 유산균과 복합 배양된 유산균을 파쇄하기 위해 각각 총 100ml의 균주를 확보한 후, 20 ~ 50분 동안 50 ~ 60kHz의 초음파 처리하여 균주를 파쇄하였다. 파쇄된 균주와 그 파쇄액을 60 ℃에서 500㎖ ~ 1L 열수 추출하여 균주의 추출액을 얻어 향장 항산화 활성 실험을 진행하였다.First, in order to disrupt the cultured lactic acid bacteria and the lactic acid bacteria complex-cultured, a total of 100 ml of each strain was obtained, and then, for 20 to 50 minutes The strains were disrupted by sonication at 50-60 kHz. The crushed strain and the crushed solution were incubated at 60 DEG C 500 ml ~ 1 L of hot water was extracted and the extract of the strain was obtained.

라디칼 소거능 실험은 자유라디칼을 소거할 수 있는 능력을 통해 항산화능을 보는 실험으로 라디칼 소거능을 측정한 결과, 피부유래 복합 배양 균주의 파쇄물의 농도의존적으로 라디칼 소거율이 높아지는 것을 확인할 수 있었으며, 복합 배양 균주 파쇄물의 농도가 100%(v/v)일 때 약 30%에 달하는 라디칼 소거능을 보임을 알 수 있었다(도 4 참조). 이러한 결과는 Lactobacillus rhamnosus HK-9 KCCM11349P와 Lactobacillus paracasei HS-05 KCCM11254P의 복합배양 균주 자체의 성분에서 라디칼을 소거하는 효과가 있음을 나타내는 것이다.The radical scavenging ability test showed that the radical scavenging ability was enhanced by the ability of scavenging free radicals, and the radical scavenging activity was measured. As a result, it was confirmed that the radical scavenging ratio of the complex- It was found that when the concentration of the strain was 100% (v / v), it showed a radical scavenging ability of about 30% (see FIG. 4). These results suggest that Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei HS-05 &lt; / RTI &gt; KCCM11254P.

환원력은 산화된 물질을 본래의 물질로 환원시키는 힘으로써 항산화 활성을 판단하는 지표가 된다. 환원력을 측정한 결과, 피부유래 복합균주 배양 파쇄물의 모든 농도에서 각각 단일의 피부유래 유산균 배양 균주의 파쇄물보다 흡광도 값이 증가하였으며, 특히 100 %(v/v)의 농도에서 1.473의 흡광도 값을 보여 가장 높은 항산화 활성을 보임을 알 수 있었다(도 5 참조).Reducing power is a force for reducing the oxidized substance to the original substance and is an index for judging the antioxidant activity. As a result of the measurement of the reducing power, the absorbance value of each of the skin-derived complex-cultured lysates was higher than that of the single skin-derived lactic acid bacteria culture broth, and the absorbance value was 1.473 at 100% (v / v) The highest antioxidant activity was observed (see Fig. 5).

<< 실험예Experimental Example 4> 4>

피부유래Derived from skin 유산균  Lactobacillus 파쇄물의Crushed 미백 활성 검증 Verification of whitening activity

본 발명자들은 본 발명의 Lactobacillus rhamnosus HK-9 KCCM11349P와 Lactobacillus paracasei HS-05 KCCM11254P를 복합 배양하여 균주 자체에서 나오는 미백 활성 물질의 효능을 검증하기 위하여 실험예 3과 동일한 방법으로 균주를 파쇄한 뒤 멜라닌 합성 저해능 실험(Melanin synthesis inhibition activity)과 티로시네이즈 저해 실험(Tyrosinase inhibition) 실험을 진행하였다.The present inventors have found that the Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei In order to test the efficacy of the whitening active substance produced from the strain itself by the combined culture of HS-05 KCCM11254P, the strain was disrupted in the same manner as in Experimental Example 3, and melanin synthesis inhibition activity and tyrosinase inhibition experiment Tyrosinase inhibition experiments were performed.

농도별(25, 50, 75, 100%(v/v))로 처리한 시료와 멜라노사이트(Melanocyte)인 Clone-M3 세포를 이용하여 멜라닌 생합성과 세포 생존율에 미치는 영향을 관찰한 결과, 피부유래 복합 배양 균주의 파쇄물 농도의존적으로 멜라닌 합성 저해율이 높아짐을 알 수 있었으며, 이는 각각 단일의 피부유래 유산균 파쇄물의 멜라닌 합성 저해율보다 높았고 특히 피부유래 복합 배양 균주의 농도가 100 %(v/v)일 때 약 35%의 멜라닌 저해능을 보임을 알 수 있었다(도 6 참조).The effects of melanocyte clone-M3 cells on melanin biosynthesis and cell survival were investigated using the samples treated with different concentrations (25, 50, 75, 100% (v / v)) and melanocytes It was found that the inhibition rate of melanin synthesis was increased depending on the lysate concentration of the complex culture strain, which was higher than the inhibition rate of melanin synthesis of the single skin-derived lysophosphate bacterium. In particular, when the concentration of the skin-derived complex culture was 100% (v / v) And showed about 35% melanin inhibition (see FIG. 6).

또한, 티로시네이즈 저해 실험(Tyrosinase inhibition)을 한 결과, 각각 단일의 피부유래 균주 파쇄물의 티로시네이즈 저해율은 최대 28%였지만, 복합 균주 배양 파쇄물의 티로시네이즈 저해율은 최대 35%를 보임을 알 수 있었다(도 7 참조).In addition, as a result of tyrosinase inhibition, tyrosinase inhibition rate of a single skin-derived strain was 28% at maximum, but the tyrosinase inhibition rate of the complex strain culture broth was 35% at maximum (See FIG. 7).

따라서 본 발명의 Lactobacillus rhamnosus HK-9 KCCM11349P와 Lactobacillus paracasei HS-05 KCCM11254P를 복합 배양하였을 때 Lactobacillus rhamnosus HK-9 KCCM11349P와 Lactobacillus paracasei HS-05 KCCM11254P를 각각 배양했을 때 보다 최대의 효율을 보여 미백 관련 화장품으로 사용이 유리하다.Therefore, the Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei When HS-05 KCCM11254P was cultured in combination, Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei HS-05 KCCM11254P, respectively, and thus it is advantageous to use it as a whitening-related cosmetic product.

이제까지 본 발명에 대하여 그 바람직한 실시예들을 중심으로 살펴보았다. 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자는 본 발명이 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 변형된 형태로 구현될 수 있음을 이해할 수 있을 것이다. 그러므로 개시된 실시예들은 한정적인 관점이 아니라 설명적인 관점에서 고려되어야 한다. 본 발명의 범위는 전술한 설명이 아니라 특허청구범위에 나타나 있으며, 그와 동등한 범위 내에 있는 모든 차이점은 본 발명에 포함된 것으로 해석되어야 할 것이다.The present invention has been described with reference to the preferred embodiments. It will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the spirit and scope of the invention as defined by the appended claims. Therefore, the disclosed embodiments should be considered in an illustrative rather than a restrictive sense. The scope of the present invention is defined by the appended claims rather than by the foregoing description, and all differences within the scope of equivalents thereof should be construed as being included in the present invention.

한국미생물보존센터(국외)Korea Microorganism Conservation Center (overseas) KCCM11254PKCCM11254P 2012021720120217 한국미생물보존센터(국외)Korea Microorganism Conservation Center (overseas) KCCM11349PKCCM11349P 2013010820130108

Claims (5)

삭제delete 삭제delete 삭제delete (a) 락토바실러스 람노서스(Lactobacillus rhamnosus) HK-9 KCCM11349P 및 락토바실러스 파라카제이(Lactobacillus paracasei) HS-05 KCCM11254P 균주 100ml을 20 ~ 50분 동안 50 ~ 60kHz의 초음파 처리하여 균주를 파쇄하는 단계; 및
(b) 상기 (a)단계에서 파쇄된 균주와 그 파쇄액을 60℃의 물 500㎖ ~ 1L을 첨가하여 12 ~ 24 시간동안 열수추출하는 단계를 포함하는 항산화용 화장료 조성물을 제조하는 방법.
(a) Lactobacillus rhamnosus HK-9 KCCM11349P and Lactobacillus paracasei . HS-05 100 ml of KCCM11254P strain is sonicated at 50 to 60 kHz for 20 to 50 minutes to disrupt the strain; And
(b) adding 500 ml to 1 L of water at 60 ° C. to the strain and the disrupted solution obtained in step (a), and extracting the mixture by hot water for 12 to 24 hours.
황금 100 중량부 대비 락토바실러스 람노서스(Lactobacillus rhamnosus) HK-9 KCCM11349P 및 락토바실러스 파라카제이(Lactobacillus paracasei) HS-05 KCCM11254P 균주를 각각 10 내지 500 중량부 첨가하여 45 ~ 50시간 동안 발효하는 단계;를 포함하는 항산화용 화장료 조성물을 제조하는 방법으로서,
상기 방법으로 제조된 조성물에는 항산화 활성을 갖는 총 페놀함량이 7.08 mg/ml으로 포함되어 있는 것을 특징으로 하는 항산화용 화장료 조성물 제조 방법.
100 parts by weight of Lactobacillus rhamnosus ( Lactobacillus rhamnosus ) HK-9 KCCM11349P and Lactobacillus paracasei HS-05 KCCM11254P strains each in an amount of 10 to 500 parts by weight, and fermenting the mixture for 45 to 50 hours, the method comprising:
Wherein the composition prepared by the above method contains 7.08 mg / ml of total phenol having antioxidant activity.
KR1020147009394A 2013-07-23 2013-07-23 Method of fermentation using complex strains and cosmetic composition comprising thereof KR101627850B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2013/006599 WO2015012421A1 (en) 2013-07-23 2013-07-23 Method for producing fermented material using complex strains derived from human body and functional cosmetic composition containing the fermented material

Publications (2)

Publication Number Publication Date
KR20150020521A KR20150020521A (en) 2015-02-26
KR101627850B1 true KR101627850B1 (en) 2016-06-07

Family

ID=52393448

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147009394A KR101627850B1 (en) 2013-07-23 2013-07-23 Method of fermentation using complex strains and cosmetic composition comprising thereof

Country Status (2)

Country Link
KR (1) KR101627850B1 (en)
WO (1) WO2015012421A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190055552A (en) 2017-11-15 2019-05-23 한국식품연구원 Lactobacillus plantarum WiKim0060 having skin whitening and skin moisturizing activities and composition for comprising the same
KR102247810B1 (en) * 2020-09-23 2021-05-04 (주)에스디생명공학 Composition Comprising Mixed Culture Strain of Lactobacillus sp. SDCM 1003 and SDCM 1105, Culture Fluid, or Culture Fluid Extract thereof as Active Ingredient
KR102310898B1 (en) 2021-02-16 2021-10-08 주식회사 메디오젠 Composition for anti-oxidant comprising dried powder of culture of Lactobacillus acidophilus
KR102693965B1 (en) 2023-10-05 2024-08-12 (주) 옵트바이오 Composition for Improving Condition of Skin Containing Plant Originated Probiotics Fermentation product of Natural Complex Extract

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101951782B1 (en) * 2010-10-25 2019-02-25 (주)아모레퍼시픽 Cosmetic composition for whitening containing green tea extract
KR102132827B1 (en) 2015-10-21 2020-07-22 주식회사 단정바이오 Novel lactobacillus rhamnosus vitaP1 and fermentation product method of pueraria radix or soybean using lactobacillus rhamnosus vitaP1 and fermentation product of pueraria radix or soybean using lactobacillus rhamnosus vitaP1
KR101965482B1 (en) * 2016-10-28 2019-04-03 건국대학교 산학협력단 Cosmetic composition for recovering damaged skin barriers and improving aged skin comprising Lactobacillus rhamnosus as an active ingredient
KR101938864B1 (en) * 2016-11-03 2019-01-16 주식회사 쎌바이오텍 Composition for antioxidation and improvement of skin conditions
KR102015180B1 (en) * 2017-10-30 2019-08-27 건국대학교 산학협력단 Cosmetic composition comprising the fermented milk-cream broth of lactic acid bacteria
EP3746186A1 (en) * 2018-02-02 2020-12-09 Postbiotica S.R.L. Use of a postbiotic-based composition for the treatment of skin diseases
FR3090383B1 (en) * 2018-12-21 2021-05-28 Lvmh Rech Composition comprising an extract of Lactobacillus rhamnosus
KR102074383B1 (en) * 2019-04-26 2020-02-06 주식회사 락토메이슨 Skin-whitening cosmetic composition comprising lactobacillus rhamnosus lm1011 having immunostimulating activity
KR102249070B1 (en) * 2019-09-10 2021-05-06 서울시립대학교 산학협력단 Lactobacillus paracasei subsp. tolerans SW1 producing the natural metabolites for improving wrinkles and uses thereof
KR102104214B1 (en) * 2019-12-24 2020-04-23 오한상 Cosmetic composition comprising potassium alum
KR102263454B1 (en) * 2019-12-27 2021-06-10 주식회사 세바바이오텍 Skin derived novel lactic acid bacteria having effects of enhancing skin barrier and anti-wrinkle and use thereof
KR102194314B1 (en) * 2020-06-24 2020-12-23 주식회사 아미코스메틱 Antioxidant or skin microbiome balance cosmetic composition comprising green tea fermented extract fermented by inoculating lactobacillus rhamnosus strain
CN114452241A (en) * 2022-03-16 2022-05-10 渤海大学 Probiotic small-molecule facial mask and preparation method thereof
KR102585337B1 (en) * 2022-10-13 2023-10-10 록야 주식회사 Manufacturing method of postbiotics using Lactobacillus rhamnosus B3421 isolated from ginseng sprout and composition comprising the same
CN115836997A (en) * 2022-11-02 2023-03-24 菏泽市亿鑫生物科技有限公司 Mung bean seed fermented product, skin external preparation containing mung bean seed fermented product, and preparation method and application of mung bean seed fermented product

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005525348A (en) * 2002-02-21 2005-08-25 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム Photoprotective orally administrable composition for skin
JP2010138147A (en) * 2008-12-15 2010-06-24 Op Bio Factory Co Ltd Melanogenesis inhibitor, antioxidant, anti-inflammatory agent, external preparation for skin, and food and beverage

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040166A1 (en) * 2004-03-31 2004-06-30 Alberto Cresci BACTERIAL STRAINS LAB WITH PROBIOTIC PROPERTIES AND COMPOSITIONS THAT CONTAIN THE SAME.
KR20080094459A (en) * 2007-04-20 2008-10-23 주식회사 엘지생활건강 Cosmetic composition having antioxidation activity
KR100962052B1 (en) * 2007-05-11 2010-06-08 주식회사 코리아나화장품 Cosmetic Composition for Improving the Acne containing Lactobacillus rhamnosus or its Culture Medium As Active Ingredient
CN102470151B (en) * 2009-07-16 2013-07-24 国立大学法人广岛大学 Prophylactic, ameliorating or therapeutic agent for oral diseases
KR101163101B1 (en) * 2009-08-17 2012-07-06 서울대학교산학협력단 Food composition containing the Scutellaria baicalensis George biologically converted by lactic acid bacteria or lysate of lactic acid bacteria with anti-allergenic effect
KR101263068B1 (en) * 2010-04-08 2014-04-21 경희대학교 산학협력단 Composition for Inhibiting Skin Aging
WO2011141762A1 (en) * 2010-05-12 2011-11-17 Compagnie Gervais Danone Synergistic fermentation of lactobacillus rhamnosus and lactobacillus paracasei subsp paracasei
JP6073857B2 (en) * 2011-04-08 2017-02-01 セーホーエル.ハンセン アクティーゼルスカブ Synthetic antimicrobial effect

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005525348A (en) * 2002-02-21 2005-08-25 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム Photoprotective orally administrable composition for skin
JP2010138147A (en) * 2008-12-15 2010-06-24 Op Bio Factory Co Ltd Melanogenesis inhibitor, antioxidant, anti-inflammatory agent, external preparation for skin, and food and beverage

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190055552A (en) 2017-11-15 2019-05-23 한국식품연구원 Lactobacillus plantarum WiKim0060 having skin whitening and skin moisturizing activities and composition for comprising the same
KR102070143B1 (en) 2017-11-15 2020-01-29 한국식품연구원 Lactobacillus plantarum WiKim0060 having skin whitening and skin moisturizing activities and composition for comprising the same
KR102247810B1 (en) * 2020-09-23 2021-05-04 (주)에스디생명공학 Composition Comprising Mixed Culture Strain of Lactobacillus sp. SDCM 1003 and SDCM 1105, Culture Fluid, or Culture Fluid Extract thereof as Active Ingredient
KR102310898B1 (en) 2021-02-16 2021-10-08 주식회사 메디오젠 Composition for anti-oxidant comprising dried powder of culture of Lactobacillus acidophilus
KR102693965B1 (en) 2023-10-05 2024-08-12 (주) 옵트바이오 Composition for Improving Condition of Skin Containing Plant Originated Probiotics Fermentation product of Natural Complex Extract

Also Published As

Publication number Publication date
KR20150020521A (en) 2015-02-26
WO2015012421A1 (en) 2015-01-29

Similar Documents

Publication Publication Date Title
KR101627850B1 (en) Method of fermentation using complex strains and cosmetic composition comprising thereof
KR101388918B1 (en) Lactobacillus rhamnosus HK-9 derived from human body, and fermented material and cosmetic composition using it
KR101440469B1 (en) Method of fermented wild ginseng root using complex strains and cosmetic composition comprising thereof
KR101068815B1 (en) Cosmetic composition for improving skin wrinkle and skin whitening comprising a soybean compound fermented by kimchi lactic acid bacteria complex
KR101103283B1 (en) The Manufacturing Method of Fermented Aloe for Whitening Effect in skin, and the Functional Whitening Cosmetics Containing Fermented Aloe
KR101375775B1 (en) Functional cosmetic materials using Wax Gourd and The Manufacturing Method
KR101353054B1 (en) fermented product and manufacturing method thereof, food composition cosmetic and compositon
CN112569150B (en) Cosmetic composition comprising seedling ginseng ferment and preparation method thereof
KR102173646B1 (en) Streptococcus salivarius sbk4 strain isolated from skin and functional cosmetic composition comprising Streptococcus salivarius sbk4 strain
KR101875001B1 (en) Lactobacillus fermentum GFCSJ and cacao nibs Fermented extract Manufactured Using Thereof
KR102553057B1 (en) Compositions comprising skin derived lactic acid bacteria having effects of anti-oxidation, anti-inflammation and whitening
JP6321401B2 (en) Cosmetics
KR20160074116A (en) Cosmetic composition containing Crataegis fructus fermented extract
KR101810141B1 (en) Lactobacillus plantarum HK and Telopea speciosissima Fermented extract Manufactured Using Thereof
KR101194226B1 (en) Cosmetic composition for antioxidant and whitening effects having fermented paprika extract and manufacturing method thereof
KR102263454B1 (en) Skin derived novel lactic acid bacteria having effects of enhancing skin barrier and anti-wrinkle and use thereof
KR20130001842A (en) Cosmetic composition and makeup method for the skin whitening comprising the styrax obassia extracts
KR20150084397A (en) Composition for whitening containing fermented ginseng seed oil
KR102014312B1 (en) Skin-whitening functional composition including polyopes affinis extracts
KR102221097B1 (en) Cosmetic composition for stress relief and skin barrier improvement
KR20190037436A (en) Cosmetic composition including fermented water lily extract and method for manufacturing the same
KR20110105243A (en) Cosmetic composition for the skin whitening comprising phaseolus radiatus seed extracts by fermentation and enzyme treatment
KR101258991B1 (en) Preparation method of arctigenin including fermentation of microorganism in medium containing arctium lappa l.
KR102244812B1 (en) Composition Comprising Mixed Culture Strain of Lactobacillus plantarum subsp. plantarum SDCM 1002 and Saccharomyce cerevisiae SDCM 3017, Culture Fluid, or Culture Fluid Extract thereof as Active Ingredient
KR102668617B1 (en) Leuconostoc mesenteroides strain and cosmetic composition containing the same

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
FPAY Annual fee payment

Payment date: 20190502

Year of fee payment: 4